HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.

Abstract
c-Jun N-terminal kinase (JNK) is a member of the mitogen-activated protein kinase family, and its function is critical for signal transduction in tumor and endothelial cells. JNK is a serine/threonine protein kinase that phosphorylates c-Jun, a component of the activator protein-1 transcription factor complex. We hypothesize that inhibiting JNK will lead to the inhibition of tumor growth; therefore, we evaluated the efficacy of the recently described JNK inhibitor SP600125 [anthra[1,9-cd] pyrazol-6 (2H)-one]. SP600125 is an anthrapyrazole that is a reversible, ATP-competitive inhibitor of JNK1/2. SP600125 exhibited broad-based antiproliferative activity in human endothelial and tumor cell lines. SP600125 affects proliferation by arresting cells in the G2/M phase of the cell cycle. SP600125 also acts to inhibit endothelial cell migration. In cell lines, a correlation of cell growth inhibition with reduced JNK activity was observed. The systemic administration of SP600125 resulted in the inhibition of DU145 human prostate carcinoma xenografts and murine Lewis lung carcinoma. SP600125 also enhanced the potency of cyclophosphamide in the inhibition of Lewis lung tumor growth. These data indicate the therapeutic antitumor potential of small molecule inhibitors that act to block the cellular activity of JNK.
AuthorsBruce W Ennis, Kimberly E Fultz, Kent A Smith, John K Westwick, Dan Zhu, Michael Boluro-Ajayi, Graham K Bilter, Bernd Stein
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 313 Issue 1 Pg. 325-32 (Apr 2005) ISSN: 0022-3565 [Print] United States
PMID15626722 (Publication Type: Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Anthracenes
  • Antineoplastic Agents
  • pyrazolanthrone
Topics
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Anthracenes (pharmacology, therapeutic use)
  • Antineoplastic Agents (pharmacology)
  • Blotting, Western
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Disease Progression
  • Endothelial Cells (drug effects)
  • Female
  • Flow Cytometry
  • G2 Phase (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Neoplasms (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: